EMAIL THIS PAGE TO A FRIEND

Gene therapy

Gene delivery to the spinal cord using MRI-guided focused ultrasound.


PMID 25781651

Abstract

Non-invasive gene delivery across the blood-spinal cord barrier (BSCB) remains a challenge for treatment of spinal cord injury and disease. Here, we demonstrate the use of magnetic resonance image-guided focused ultrasound (MRIgFUS) to mediate non-surgical gene delivery to the spinal cord using self-complementary adeno-associated virus serotype 9 (scAAV9). scAAV9 encoding green fluorescent protein (GFP) was injected intravenously in rats at three dosages: 4 × 10(8), 2 × 10(9) and 7 × 10(9) vector genomes per gram (VG g(-1)). MRIgFUS allowed for transient, targeted permeabilization of the BSCB through the interaction of focused ultrasound (FUS) with systemically injected Definity lipid-shelled microbubbles. Viral delivery at 2 × 10(9) and 7 × 10(9) VG g(-1) leads to robust GFP expression in FUS-targeted regions of the spinal cord. At a dose of 2 × 10(9) VG g(-1), GFP expression was found in 36% of oligodendrocytes, and in 87% of neurons in FUS-treated areas. FUS applications to the spinal cord could address a long-term goal of gene therapy: delivering vectors from the circulation to diseased areas in a non-invasive manner.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

D27802
1,4-Diazabicyclo[2.2.2]octane, ReagentPlus®, ≥99%
C6H12N2
SAB2501501
Anti-FOXC1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1412610
ANTI-FOXC1 antibody produced in mouse, clone 1E11, purified immunoglobulin, buffered aqueous solution
AV32300
Anti-FOXC1 antibody produced in rabbit, IgG fraction of antiserum
HPA040670
Anti-FOXC1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4500920
Anti-FOXC1 antibody produced in rabbit, affinity isolated antibody
SAB2104365
Anti-FOXC1, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB2105271
Anti-FOXC1, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB2500410
Anti-FOXC1, C-Terminal antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB3700280 Anti-goat IgG (H+L) antibody produced in donkey, affinity isolated antibody, buffered aqueous solution
SAB3700328 Anti-Goat IgG (H+L), F(ab) fragment- antibody produced in donkey, affinity isolated antibody, buffered aqueous solution
AV32753
Anti-OLIG2 (AB1) antibody produced in rabbit, affinity isolated antibody
AV31464
Anti-OLIG2 (AB2) antibody produced in rabbit, affinity isolated antibody
AV32752
Anti-OLIG2 (AB3) antibody produced in rabbit, affinity isolated antibody
SAB1412293
ANTI-OLIG2 antibody produced in mouse, clone 2A8, purified immunoglobulin, buffered aqueous solution
SAB1412294
ANTI-OLIG2 antibody produced in mouse, clone 2B11, purified immunoglobulin, buffered aqueous solution
HPA003254
Anti-OLIG2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
203025
Cesium chloride, ≥99.999% trace metals basis
ClCs
449733
Cesium chloride, anhydrous, beads, −10 mesh, 99.999% trace metals basis
ClCs
C3139
Cesium chloride, optical grade, ≥99.5% trace metals basis
ClCs
C3011
Cesium chloride, Grade I, ≥99.0%
ClCs
562599
Cesium chloride, 99.99% trace metals basis
ClCs
C3032
Cesium chloride, for molecular biology, ≥99% (silver nitrate titration)
ClCs
C4036
Cesium chloride, for molecular biology, ≥98%
ClCs
C3309
Cesium chloride, BioXtra, ≥99.5% (titration)
ClCs
C6914
Cesium chloride, Grade II, ≥98%
ClCs
20966
Cesium chloride, BioUltra, for molecular biology, ≥99.5% (AT)
ClCs
290734
Dabco® 33-LV
C6H12N2
SAB1403824
Monoclonal Anti-FOXC1, (C-terminal) antibody produced in mouse, clone 4D11, purified immunoglobulin, buffered aqueous solution
WH0010215M2
Monoclonal Anti-OLIG2 antibody produced in mouse, clone 3D7, purified immunoglobulin, buffered aqueous solution